Volume 1 · Issue 2

Precision Neurology

Clinical research on diagnosis, classification and biomarkers across epilepsy, neuroimmunology, headache and disorders of the peripheral nervous system.

100 Creative Commons readings · Paulina Valenzuela, MD, Editor-in-Chief

Issue 2 · Reading list

Explore the research

Download issue catalog

100 readings · Page 4 of 5

  1. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Mechanisms of Chemotherapy-Induced Peripheral Neuropathy.

    Renata Zajączkowska, Magdalena Kocot-Kępska, Wojciech Leppert, Anna Wrzosek et al.

    International journal of molecular sciences · 2019

    Original article
  2. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.

    Hana Starobova, Irina Vetter

    Frontiers in molecular neuroscience · 2017

    Original article
  3. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations.

    Laura Dresser, Richard Wlodarski, Kourosh Rezania, Betty Soliven

    Journal of clinical medicine · 2021

    Original article
  4. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature.

    Houssein Safa, Daniel H Johnson, Van Anh Trinh, Theresa E Rodgers et al.

    Journal for immunotherapy of cancer · 2019

    Original article
  5. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Regulatory T cells in multiple sclerosis and myasthenia gravis.

    K M Danikowski, S Jayaraman, B S Prabhakar

    Journal of neuroinflammation · 2017

    Original article
  6. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy.

    Preet G S Makker, Samuel S Duffy, Justin G Lees, Chamini J Perera et al.

    PloS one · 2017

    Original article
  7. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Insulin-regulated serine and lipid metabolism drive peripheral neuropathy.

    Michal K Handzlik, Jivani M Gengatharan, Katie E Frizzi, Grace H McGregor et al.

    Nature · 2023

    Original article
  8. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.

    Nico Melzer, Tobias Ruck, Peter Fuhr, Ralf Gold et al.

    Journal of neurology · 2016

    Original article
  9. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    The risk factors for diabetic peripheral neuropathy: A meta-analysis.

    Xiuxiu Liu, Yuyan Xu, Miaomiao An, Qibing Zeng

    PloS one · 2019

    Original article
  10. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN).

    Annalisa Canta, Eleonora Pozzi, Valentina Alda Carozzi

    Toxics · 2015

    Original article
  11. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options.

    Raffaele Galiero, Alfredo Caturano, Erica Vetrano, Domenico Beccia et al.

    International journal of molecular sciences · 2023

    Original article
  12. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy.

    Ines Klein, Helmar C Lehmann

    Toxics · 2021

    Original article
  13. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy.

    Alex Molassiotis, Hui Lin Cheng, Violeta Lopez, Joseph S K Au et al.

    BMC cancer · 2019

    Original article
  14. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Burden of disease in myasthenia gravis: taking the patient's perspective.

    Sophie Lehnerer, Jonas Jacobi, Ralph Schilling, Ulrike Grittner et al.

    Journal of neurology · 2021

    Original article
  15. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy.

    Giulia Fumagalli, Laura Monza, Guido Cavaletti, Roberta Rigolio et al.

    Frontiers in immunology · 2021

    Original article
  16. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Updates in diabetic peripheral neuropathy.

    Kelsey Juster-Switlyk, A Gordon Smith

    F1000Research · 2016

    Original article
  17. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin.

    Christian Maihöfner, Ingo Diel, Hans Tesch, Tamara Quandel et al.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021

    Original article
  18. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    Alcohol-related peripheral neuropathy: a systematic review and meta-analysis.

    Thomas Julian, Nicholas Glascow, Rubiya Syeed, Panagiotis Zis

    Journal of neurology · 2018

    Original article
  19. Neuromuscular and peripheral nerve disorders · CC BY 3.0

    The epidemiology of myasthenia gravis.

    Ana-Maria Bubuioc, Aigerim Kudebayeva, Saule Turuspekova, Vitalie Lisnic et al.

    Journal of medicine and life · 2021

    Original article
  20. Neuromuscular and peripheral nerve disorders · CC BY 4.0

    The anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse model.

    Qi-Liang Mao-Ying, Annemieke Kavelaars, Karen Krukowski, Xiao-Jiao Huo et al.

    PloS one · 2014

    Original article